162635-04-3 Temsirolimus AKSci B622
 
 
Loading Please Wait...
  B622    
Temsirolimus, 99% (HPLC)
 
42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin, CCI-779
IDENTITY
CAS Number:162635-04-3
MDL Number:MFCD00934421
MF:C56H87NO16
MW:1030.29
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:99% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:155-165°C
Long-Term Storage:Store long-term at -20°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:DMSO: >=20 mg/mL
Application(s):Specific mTOR inhibitor
Form:Free Base
Research Area:soft tissue sarcoma,multiple myeloma,cancer

REFERENCES
[1]Joseph Boni.; Cathie Leister.; Jaime Burns.; Maria Cincotta.; Bruce Hug.; Laurence Moore. Pharmacokinetic Profile of Temsirolimus With Concomitant Administration of Cytochrome P450-Inducing Medications1.The Journal of Clinical Pharmacology.2007, (11), 1430-1439.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501

Current as of April 25, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



PubChem